OGI — ORGANIGRAM GLOBAL INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1620737 ·
Ontario, Canada
Last close
$1.11
Market Cap
$156.26M
52W High
$1.66
52W Low
$1.04
ADV30
895,183
Next earnings
2026-08-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 59,794,000 | 16,407,000 | -9,793,000 | -921,000 | 521,312,000 | 4,292,000 | 149,500,000 |
| Dec 2025 | 63,538,000 | 23,315,000 | -3,418,000 | 19,969,000 | 530,673,000 | 7,576,000 | 161,217,000 |
| Sep 2025 | 80,061,000 | 31,838,000 | 1,189,000 | -37,964,000 | 562,211,000 | 28,200,000 | 213,081,000 |
| Jun 2025 | 70,792,000 | 26,146,000 | -2,105,000 | -6,294,000 | 564,615,000 | 35,876,000 | 179,119,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-19,424,000
Investing CF
$-23,857,000
Financing CF
$39,085,000
CapEx
$-19,917,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.21
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-588,758,000
Inventory
$132,711,000
Receivables
$49,941,000
ST Investments
$805,000
EBIT TTM
$-11,917,000
Pretax Income TTM
$4,397,000
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$274,184,992
EBITDA
$3,722,000
Free Cash Flow
$17,044,624
Enterprise Value
$195,770,992
Total Cash
$5,103,000
Total Debt
$0
Shares Out
140,775,022
Trailing EPS
$-0.16
Book Value
$1.99
ROE
-5.9%
ROA
-1.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 259,183,000 | -15,300,000 | -24,759,000 | 562,211,000 | 213,081,000 | — | -7,591,000 |
| Sep 2024 | 159,841,000 | -34,756,000 | -45,440,000 | 407,860,000 | 101,871,000 | — | 3,872,000 |
| Aug 2022 | 145,809,000 | -38,752,000 | -14,283,000 | 577,107,000 | 69,049,000 | — | -36,211,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.02
Max Pain — expiry 2026-06-18
max pain strike: $1.00 · spot: $1.11 · call oi: 5,987 · put oi: 320
Expected Move to 2026-06-18:
±$0.20
(18.02%) —
implied range
$0.91 –
$1.31
· ATM straddle on $1.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NRXP | NRX Pharmaceuticals, Inc. | $156.15M | $4.31 | — |
| HURA | TuHURA Biosciences, Inc./NV | $156.02M | $2.45 | — |
| TTRX | Turn Therapeutics Inc. | $159.66M | $5.36 | — |
| ASRT | Assertio Holdings, Inc. | $151.60M | $23.46 | — |
| MENS | Jyong Biotech Ltd. | $161.09M | $2.17 | — |
News headlines (Yahoo Finance, 1h cache)
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
2026-05-18 14:03 · Yahoo
OrganiGram Holdings Reports Q2 2026 Results: Full Earnings Call Transcript
2026-05-13 09:11 · Yahoo
Transcript: OrganiGram Holdings Q2 2026 Earnings Conference Call
2026-05-13 09:10 · Yahoo
Organigram Global Inc (OGI) Q2 2026 Earnings Call Highlights: Navigating Challenges and Seizing ...
2026-05-12 19:01 · Yahoo
Cannabis Revenue Decline Pressures Organigram Earnings Despite Germany Expansion (OGI)
2026-05-12 15:05 · Yahoo
OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates
2026-05-12 13:15 · Yahoo
Organigram Global Q2 Earnings Call Highlights
2026-05-12 13:07 · Yahoo
Organigram Global Swings to Q2 Net Loss, Net Revenue Falls; Updates Fiscal 2026 Guidance
2026-05-12 11:54 · Yahoo
Organigram Reports Second Quarter Fiscal 2026 Results
2026-05-12 10:00 · Yahoo
Organigram to Report Second Quarter Fiscal 2026 Results on May 12th, 2026
2026-05-06 10:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.